ArticleCureus2025
Battling Influenza in Elderly Patients: A Case of Severe Influenza A With Complications in a High-Risk Patient.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza is a significant cause of morbidity and mortality in the elderly, particularly in those with chronic comorbidities and age-related immunosenescence. This case report details an 80-year-old male with a history of hyperlipidemia, diabetes mellitus, and dementia who developed a severe influenza A infection complicated by sepsis and hypoxic respiratory failure. Upon admission, the patient presented with fever, cough, and weakness, and was initially treated for viral pneumonia. Despite negative blood and urine cultures, influenza A was confirmed via reverse transcription polymerase chain reaction (RT-PCR). The patient developed hypotension, was unresponsive to fluid resuscitation, and was transferred to the ICU for pressor support with norepinephrine and albumin. During his intensive care unit (ICU) stay, septic shock was managed with norepinephrine, with a target mean arterial pressure (MAP) of >65 mmHg. The patient also received respiratory support, initially on a 10L high-flow nasal cannula, and was later downgraded to a 4L nasal cannula. A sacral pressure ulcer and MRSA colonization further complicated his hospital course. Antibiotic therapy included ceftriaxone, azithromycin, and vancomycin, and the patient's condition gradually improved, allowing for transfer to the intermediate care unit (IMCU) after seven days. This case underscores the importance of early antiviral therapy, the need for vigilant monitoring for secondary infections, and timely intervention to manage complications such as sepsis in elderly patients. Enhanced vaccination coverage and preventive measures are critical for reducing the incidence of severe influenza and associated complications in at-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.